Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Rollforward of Goodwill

The following is a rollforward of the Company’s goodwill by segment ($ in millions):  

	Biotechnology		Life Sciences		Diagnostics		Total
Balance, January 1, 2024	$	22,477	$	12,221	$	6,910	$	41,608
Attributable to 2024 acquisitions	—		305		—		305
Adjustments due to finalization of purchase price adjustments	—		(23)		—		(23)
Foreign currency translation and other	(1,040)		(198)		(155)		(1,393)
Balance, December 31, 2024	21,437		12,305		6,755		40,497
Adjustments due to finalization of purchase price allocations	—		9		—		9
Foreign currency translation and other	1,876		542		227		2,645
Balance, December 31, 2025	$	23,313	$	12,856	$	6,982	$	43,151

Schedule of Finite-lived Intangible Assets and Indefinite-lived Intangible Assets by Major Class

The following summarizes the gross carrying value and accumulated amortization for each major category of intangible assets as of December 31 ($ in millions): 

	2025				2024
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangibles:
Patents and technology	$	16,229	$	(6,100)	$	14,781	$	(4,641)
Customer relationships, trade names and other intangibles	10,505		(5,703)		9,972		(4,781)
Total finite-lived intangibles	26,734		(11,803)		24,753		(9,422)
Indefinite-lived intangibles:
Trademarks and trade names	2,886		—		3,237		—
Total intangibles	$	29,620	$	(11,803)	$	27,990	$	(9,422)